Insights

In Conversation with Cloud Pharmaceuticals’ Don Van Dyke

In Conversation with Cloud Pharmaceuticals’ Don Van Dyke

Artificial intelligence is one of the hottest topics in the pharmaceutical industry and there seems to be an almost daily stream of stories about its benefits. This is leading to questions about whether the hype is justified, and if it be shortly replaced by something else. To get an insider’s perspective, Ed Corbett a Principal at Novasecta, interviewed Don Van Dyke, Chief Operating Officer of Cloud Pharmaceuticals to hear his thoughts on what the potential of AI is and whether the hype is justified.

To read our whitepaper on “What Pharma Should Do About AI” click here

To view our content please complete the form below and submit




[acceptance your-privacy*]Please tick the box if you agree to our privacy policy (Required)[/acceptance]
 

Please click submit and wait for the page to refresh